October 13, 2014 – Invivo has expanded its breast and prostate imaging solutions portfolio with the addition of the Sentinelle product line of advanced MRI coils.
The use of breast and prostate MR imaging has been rapidly increasing. Technical advancements, such as dedicated coils that achieve high resolution imaging, have aided radiologists in the detection and characterization of breast and prostate lesions under MRI.
“The acquisition of the Sentinelle product line of advanced breast and prostate MRI coils will enable us to offer our existing customers an even broader product portfolio,” said Brent Berthy, General Manager Invivo. “This is also an excellent opportunity for us to reach new customers and markets. Looking ahead, the Sentinelle technology offers promising opportunities for future innovations to help clinicians manage breast and prostate cancer.”
The Sentinelle Breast coils bring a new collection of imaging coils to Invivo customers. Coupled with an existing variety of breast imaging coils, breast immobilization/biopsy systems, DynaCAD for image analysis and interventional planning, and a full line of MRI-compatible interventional instruments.
For more information: www.invivocorp.com
July 25, 2024 
